BrainsWay (NASDAQ:BWAY – Get Free Report) and United American Healthcare (OTCMKTS:UAHC – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.
Valuation and Earnings
This table compares BrainsWay and United American Healthcare”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BrainsWay | $31.78 million | 6.54 | -$4.20 million | $0.10 | 110.51 |
| United American Healthcare | N/A | N/A | $720,000.00 | N/A | N/A |
United American Healthcare has lower revenue, but higher earnings than BrainsWay.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BrainsWay | 0 | 0 | 3 | 0 | 3.00 |
| United American Healthcare | 0 | 0 | 0 | 0 | 0.00 |
BrainsWay currently has a consensus price target of $13.17, suggesting a potential upside of 19.16%. Given BrainsWay’s stronger consensus rating and higher possible upside, research analysts plainly believe BrainsWay is more favorable than United American Healthcare.
Insider and Institutional Ownership
30.1% of BrainsWay shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Comparatively, 14.3% of United American Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
BrainsWay has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.29, meaning that its share price is 229% less volatile than the S&P 500.
Profitability
This table compares BrainsWay and United American Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BrainsWay | 3.88% | 3.52% | 2.26% |
| United American Healthcare | N/A | N/A | N/A |
Summary
BrainsWay beats United American Healthcare on 10 of the 11 factors compared between the two stocks.
About BrainsWay
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
About United American Healthcare
United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.
Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.
